We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canadian API Maker Warned for cGMP Failures, Will Remain on Import Alert
Canadian API Maker Warned for cGMP Failures, Will Remain on Import Alert
Toronto-based active pharmaceutical ingredient maker Attix Pharmaceuticals received an FDA warning letter due to lapses in current good manufacturing practices, including failure to appropriately package drug products to avoid cross contamination.